Pelagen
Pelagen is a Leiden-based biotech startup that produces biofabricated leather from cultured cells without animals, leveraging proprietary tissue engineering IP from Leiden University Medical Center to serve fashion, automotive, and interior design brands.
- Company typePrivate
- Founded2020
- HeadquartersLeiden, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pelagen does
Pelagen is a Leiden, Netherlands-based biotech startup founded in 2020 that develops biofabricated natural materials using proprietary skin tissue engineering technology. The company's core technology engineers skin tissue from cells without animals, leveraging decades of biomedical research from Leiden University Medical Center — Europe's pioneer in skin engineering — under the leadership of CSO Prof. Abdoel el Ghalbzouri. The closely-held IP suite spans cell selection to tissue cultivation methods, enabling the production of plastic-free leather described as one-to-one comparable with traditional animal-derived leather, with planned extensions into fur and wool alternatives.
The company offers a single core product — Engineered Leather — applicable across three primary verticals: fashion (accessories, apparel, footwear), automotive (vehicle interiors), and interior design and furniture. Pelagen operates a B2B enterprise sales model targeting major brands in these verticals through direct sales, with prospective customers engaging via a 'request a deck' inquiry mechanism on the company website. Pricing is not publicly disclosed, suggesting quote-based, custom enterprise contracts. The company also references a one-time license revenue stream in source data.
Pelagen is a private, venture-backed company in early commercialization stage with 1-10 employees. It has received two funding rounds: an investment from Dutch incubator YES!Delft in October 2021 and from Dutch fund UNIIQ in October 2023, with specific amounts undisclosed. The company displays EU co-funding branding, suggesting participation in European innovation programs. No customers, revenue figures, patents, awards, or regulatory certifications are disclosed in available sources, indicating Pelagen remains in pre-commercial or early pilot-stage commercialization.
Pelagen firmographics
Firmographics- Name
- Pelagen
- Legal name
- Pelagen
- Website
- https://pelagen.bio
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Pelagen is a Leiden-based biotech startup that produces biofabricated leather from cultured cells without animals, leveraging proprietary tissue engineering IP from Leiden University Medical Center to serve fashion, automotive, and interior design brands.
- Ownership category
- akta.pro rank
Pelagen industry classification
Industry- Product category
- Biofabricated Leather Materials
- NAICS
- Leather and Allied Product Manufacturing (316), Leather and Hide Tanning and Finishing (31611), Other Leather and Allied Product Manufacturing (31699)
- SIC
- Leather & Leather Products (3100), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium) (IMAOAHAH)
- akta.pro secondary industries
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Leather, Suede & Alternatives (PU/Bio-based) (CRAAAMAG)
Keywords
Where Pelagen is headquartered
LocationHeadquarters
- HQ city
- Leiden
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Pelagen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain
Revenue model
- Biofabricated Materials Sales: Pelagen generates revenue through the sale of biofabricated leather and natural materials produced via their cell-based technology. The materials are positioned as animal-free alternatives for fashion, automotive, interiors, and other applications. The company appears to be in development/commercialization stage targeting enterprise buyers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Pelagen product offering
Product offeringCore offering
Pelagen produces biofabricated leather by engineering skin tissue from cells without animals. The proprietary technology, developed at Leiden University Medical Center, cultivates living tissue that is transformed into leather material with quality characteristics comparable to traditional animal leather, sold as an animal-free alternative for fashion, automotive, interiors, and other applications.
Product overview
Pelagen offers a single core product: Engineered Leather, a biofabricated natural material produced without animals. The company's technology engineers skin tissue from cells using proprietary methods developed at Leiden University Medical Center. The living tissue is cultivated and then transformed into leather material that matches the biological complexity and quality of traditional animal leather, serving as an animal-free alternative for fashion, automotive, interiors, and other applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Engineered Leather
Companies that use Pelagen
Customer profileSegments3 records
Ideal customer profiles3 records
Pelagen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Pelagen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Leiden University Medical CentercoreLeiden University Medical Center is Europe's pioneer in skin engineering. Pelagen leverages decades of medical research leadership from LUMC, which serves as the foundation for their tissue engineering technology and provides scientific expertise through their CSO Prof. Abdoel el Ghalbzouri.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Pelagen competitors and assessment
Company assessmentBroad incumbents
- MycoWorks: MycoWorks produces Fine Mycelium, a mycelium-based leather alternative, and has secured a high-profile partnership with Hermès. While it uses a different biology (fungal vs. mammalian cells), it competes head-to-head with Pelagen for fashion and luxury leather buyers seeking premium sustainable materials.
- Spiber: Spiber (Japan) produces Brewed Protein, a fermentation-derived protein fiber used as a leather alternative. Although fiber-based rather than cell-cultivated tissue, Spiber is a well-funded category leader pursuing apparel and automotive customers in the same premium materials market as Pelagen.
- Bolt Threads (Forager): Bolt Threads, now operating its materials business as Forager, develops mycelium- and fermentation-based leather and protein materials. It competes for the same fashion and footwear customers and has broader scale and brand partnerships than Pelagen today.
Emerging players
- Desserto: Desserto makes cactus-based vegan leather for fashion, automotive interiors, and upholstery. It overlaps with Pelagen on automotive and interior verticals but uses plant biomass rather than cell-cultivated tissue, positioning at a lower price point.
- Ecovative Design: Ecovative uses mycelium technology (Forager platform) to produce leather-like and packaging materials. It is a more established adjacent player in bio-fabricated materials with broader product lines, sharing the alternative leather end market with Pelagen.
- TômTex: TômTex develops chitosan-based (shellfish-waste-derived) leather alternatives aimed at fashion and accessories. It is a smaller, design-led entrant competing for sustainable-material brand interest similar to Pelagen's fashion customer base.
- Ananas Anam (Piñatex): Ananas Anam produces Piñatex, a pineapple-leaf-fiber leather alternative. It serves fashion and footwear brands with a plant-based, non-cultivated leather, competing for some of the same sustainable-material buyers as Pelagen but with a very different feedstock and price point.
Direct peers
- VitroLabs: VitroLabs is a California-based startup growing cell-cultivated leather from animal cells without slaughter. It pursues the same core thesis as Pelagen — animal-free leather with biological parity to conventional leather — and targets luxury fashion and automotive OEMs as initial customers.
- Modern Meadow: Modern Meadow is a US-based biotech developing cell-cultivated and bio-fabricated leather and other protein-based materials. It is the closest direct peer to Pelagen, using cell-based and fermentation-derived approaches to produce next-generation leather for fashion and automotive applications.
Others
- Leiden University Medical Center (LUMC): LUMC is Pelagen's core scientific partner and the source of its tissue-engineering IP and CSO expertise. It is not a commercial competitor but functions as an enabling research institution whose continued collaboration underpins Pelagen's technology pipeline.
Market position
Strengths4 records
Weaknesses1 record
Competitive moat3 records
Key risks1 record
Key highlights6 records
Customer concentration
Pelagen social profiles
Digital presencePelagen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pelagen leadership team
Management profileNumber of profiles
Profiles1 record
Pelagen funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pelagen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pelagen
What does Pelagen do?
Pelagen produces biofabricated leather by engineering skin tissue from cells without animals. The proprietary technology, developed at Leiden University Medical Center, cultivates living tissue that is transformed into leather material with quality characteristics comparable to traditional animal leather, sold as an animal-free alternative for fashion, automotive, interiors, and other applications.
Is Pelagen a public or private company?
Pelagen is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pelagen founded?
Pelagen was founded in 2020. It employs 1 to 10 people.
Where is Pelagen based?
Pelagen is headquartered in Leiden, Netherlands, in the Europe region.
How does Pelagen make money?
One revenue line is on record: biofabricated Materials Sales.
Who are Pelagen's main competitors?
Broad incumbents on record are MycoWorks, Spiber and Bolt Threads (Forager). Emerging players are Desserto, Ecovative Design, TômTex and Ananas Anam (Piñatex). Direct peers are VitroLabs and Modern Meadow. Leiden University Medical Center (LUMC) is listed as an others.
Does Pelagen have an API?
No public API is recorded for Pelagen.
What industry is Pelagen in?
Pelagen's product category is Biofabricated Leather Materials. Its primary akta.pro industry code is IMAOAHAH, Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 316 and its SIC code is 3100.